http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202000301-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
filingDate 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-202000301-A1
titleOfInvention COMPOSITION, DRUG, MULTI-DOSE CONTAINER, KIT
abstract The present invention relates to the use of a polysaccharide that can be obtained from a bacterial strain for the prevention and treatment of eye diseases. More specifically, the invention relates to the ophthalmic use of a polysaccharide, which can be obtained from the bacterial strain CNCM I-5038 Cobetia marina, in conditions of the eye accompanied by dry eye and eye inflammation.
priorityDate 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415805831

Total number of triples: 19.